2026-09-18T12:27:59-05:00 2025-12-31 953001179 WINDES INC 2050 MAIN ST STE 1300 IRVINE CA 92614 990 2025-01-01 208730839 LUNG CANCER FOUNDATION OF AMERICA LUNG 5073541361 7381 LA TIJERA BLVD 451663 LOS ANGELES CA 90045 JIM BARANSKI EXECUTIVE DIRECTOR 5073541361 2026-09-17 1 ELEANOR A LIVINGSTON CPA MST P00226461 9498529433 2026-09-17 2025 JIM BARANSKI 7381 LA TIJERA BLVD 451663 LOS ANGELES CA 90045 2827536 0 X WWW.LCFAMERICA.ORG X 2007 MN LCFA'S MISSION IS THE IMPROVEMENT IN SURVIVORSHIP OF LUNG CANCER PATIENTS THROUGH THE FUNDING OF TRANSFORMATIVE SCIENCE. LUNG CANCER FOUNDATION OF AMERICA IS WORKING TO CHANGE THE PUBLIC PERCEPTION OF LUNG CANCER THROUGH EDUCATION AND PERSONAL STORIES ABOUT LUNG CANCER AND TO IMPROVE PATIENT OUTCOMES THROUGH FUNDING IMPACTFUL RESEARCH.WHILE RAISING FUNDS TO SUPPORT LUNG CANCER RESEARCH, LCFA WILL RAISE THE PUBLIC'S AWARENESS AND SERVE AS A RESOURCE FOR PATIENTS OR ANYONE SEEKING ANSWERS, HOPE, AND ACCESS TO UPDATED TREATMENT INFORMATION, SCIENTIFIC INVESTIGATION, AND CLINICAL TRIALS. 12 10 8 226 0 0 2300119 2761099 0 0 33902 39582 0 0 2334021 2800681 400000 200000 0 0 615984 756387 0 0 146804 1080588 1189150 2096572 2145537 237449 655144 2114168 2516803 608408 355899 1505760 2160904 X LUNG CANCER FOUNDATION OF AMERICA (LCFA) IS WORKING TO CHANGE THE PUBLIC PERCEPTION OF LUNG CANCER THROUGH EDUCATION AND PERSONAL STORIES ABOUT LUNG CANCER AND TO IMPROVE PATIENT OUTCOMES THROUGH FUNDING IMPACTFUL RESEARCH. 0 0 1011412 200000 RESEARCH GRANT & SCIENTIFIC ADVANCMENTS: RESEARCH GRANTS: AWARDED MULTIPLE SIX-FIGURE LUNG CANCER RESEARCH GRANTS TO YOUNG INVESTIGATORS, FOCUSING ON EARLY DETECTION, TARGETED THERAPIES, AND IMMUNOTHERAPY. THESE GRANTS, MADE POSSIBLE THROUGH GENEROUS PRIVATE DONATIONS, HAVE LED TO GROUNDBREAKING DISCOVERIES IN LUNG CANCER TREATMENT. SCIENTIFIC ADVANCEMENTS: SUPPORTED RESEARCH THAT CONTRIBUTED TO SIGNIFICANT PROGRESS IN PERSONALIZED TREATMENT STRATEGIES, INCLUDING ADVANCEMENTS IN TARGETED THERAPIES AND IMMUNOTHERAPY FOR BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC). 908371 AWARENESS INITIATIVES, SPEAKERS BUREAU, FUNDRAISING SUCCESS, & COLLABORATIVE PARTNERSHIPS: AWARENESS INITIATIVES: REACHED MILLIONS OF PEOPLE THROUGH COMPREHENSIVE AWARENESS-RAISING CAMPAIGNS, EDUCATING THE PUBLIC ABOUT LUNG CANCER RISK FACTORS, EARLY DETECTION, AND TREATMENT OPTIONS.SCIENTIFIC ADVANCEMENTS: SUPPORTED RESEARCH THAT CONTRIBUTED TO SIGNIFICANT PROGRESS IN PERSONALIZED TREATMENT STRATEGIES, INCLUDING ADVANCEMENTS IN TARGETED THERAPIES AND IMMUNOTHERAPY FOR BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC). FUNDRAISING SUCCESS: SUCCESSFULLY RAISED FUNDS TO SUPPORT ONGOING RESEARCH INITIATIVES AND AWARENESS PROGRAMS, DEMONSTRATING STRONG DONOR ENGAGEMENT AND FINANCIAL STEWARDSHIP. COLLABORATIVE PARTNERSHIPS: STRENGTHENED PARTNERSHIPS WITH SISTER ORGANIZATIONS TO MAXIMIZE THE IMPACT OF RESEARCH FUNDING AND ADVOCACY EFFORTS. THROUGH THESE ACCOMPLISHMENTS, LCFA HAS CONTINUED TO MAKE SIGNIFICANT STRIDES IN IMPROVING LUNG CANCER OUTCOMES AND SUPPORTING THE LUNG CANCER COMMUNITY. 16000 COMMUNITY ENGAGEMENT: FOSTERED A SUPPORTIVE COMMUNITY FOR LUNG CANCER PATIENTS AND THEIR FAMILIES THROUGH EDUCATIONAL RESOURCES, SUPPORT PROGRAMS, AND ADVOCACY EFFORTS. 1935783 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 4 0 1 8 1 0 0 0 0 0 0 0 0 0 0 0 0 X 12 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT FL GA HI IL KS KY MD MA MI MN MS NV NH NJ NM NY NC ND OH OR PA RI SC TN UT VA WA WV WI X X GINA CRUZ 5073541361 7381 LA TIJERA BLVD 451663 LOS ANGELES CA 90045 JIM BARANSKI EXECUTIVE DIRECTOR 40.00 X X 206000 0 8770 KIM NORRIS PRESIDENT 40.00 X X 103000 0 8353 SUSAN MANDEL MD SECRETARY 10.00 X X 0 0 0 MARTA KAUFFMAN DIRECTOR 8.00 X 0 0 0 ROBERT FIGLIN MD FACP DIRECTOR 8.00 X 0 0 0 DAVID T LEVINSON DIRECTOR (THRU 03/2025) 8.00 X 0 0 0 MARTIN EDELMAN DIRECTOR 8.00 X 0 0 0 CAROLYN ZAINER DIRECTOR (THRU 03/2025) 8.00 X 0 0 0 MICHELLE SAYER DIRECTOR 8.00 X 0 0 0 TRISH COURY DIRECTOR 8.00 X 0 0 0 ZACH SHEFSKA DIRECTOR 8.00 X 0 0 0 PAULO MACHADO DIRECTOR 8.00 X 0 0 0 ANNA KONKLE DIRECTOR 8.00 X 0 0 0 JAMES HITER DIRECTOR 8.00 X 0 0 0 309000 0 17123 2 0 1 0 M&C COMMUNICATIONS 30241 W LAKE DRIVE WAGRAM NC 28396 PUBLIC RELATIONS 441572 OATMEAL HEALTH 4865 NICOLE CT SAN JOSE CA 95111 AI PATIENT EDUCATION 155977 WHOLE WHALE 1288 CONEY ISLAND AVENUE 300459 BROOKLYN NY 11230 DIGITAL STRATEGY 115188 3 1430 2759669 26855 2761099 30675 30675 35762 26855 8907 8907 8907 2800681 0 0 39582 X 200000 200000 326123 277205 16307 32611 327465 278345 16373 32747 52068 44258 2603 5207 50731 43121 2537 5073 45958 21166 7859 16933 972774 938808 33966 54354 54354 9725 69 9656 1468 1468 77136 66525 10611 9078 9078 3635 3635 15022 2923 12099 2145537 1935783 62950 146804 3482 2156 1918690 1921084 191996 583758 0 9805 2114168 2516803 183408 64259 425000 291640 608408 355899 X 1027010 1366404 478750 794500 1505760 2160904 2114168 2516803 655144 0 X 0 1 X 1 0 X 1297921 1591831 2248823 2300119 2761099 10199793 1297921 1591831 2248823 2300119 2761099 10199793 5978843 4220950 414 1203 5675 32717 30675 70684 10270477 0.41100 0.40050 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 2800681 0 2800681 0 2800681 2145537 0 2145537 0 2145537 PART X, LINE 2: FIN 48: THE FOUNDATION HAS RECEIVED TAX-EXEMPT STATUS FROM THE INTERNAL REVENUE SERVICE UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE FOUNDATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS ITS POSITION OF BEING TAX EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE FOUNDATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL AND STATE PURPOSES IS GENERALLY THREE AND FOUR YEARS, RESPECTIVELY. 1 LUNG CANCER RESEARCH GRANT 1 200000 PART I, LINE 2: DESCRIBE THE ORGANIZATION'S PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS IN THE UNITED STATES: GRANT RECIPIENTS MUST PROVIDE THE FOLLOWING INFORMATION FOR CONSIDERATION: - PLANNED SPECIFIC AIMS. - RATIONALE FOR THE PROJECT TOGETHER WITH BACKGROUND, SIGNIFICANCE AND INNOVATION OF PROPOSAL. - BRIEF STATEMENT OF THE OVERALL EXPERIMENTAL APPROACH. - BRIEF STATEMENT DESCRIBING THE CLINICAL CONTEXT IN WHICH THE BIOMARKER OR RESEARCH PROJECT WILL BE USED AND THE QUANTITATIVE PERFORMANCE THAT YOUR BIOMARKER SHOULD ACHIEVE TO SHOW CLINICAL UTILITY. - NIH BIOSKETCH OF THE APPLICANT(S) BUDGET, INCLUDING PERSONNEL, SUPPLIES, PUBLICATION COSTS, TRAVEL, CLINICAL TRIAL COSTS, ANIMAL COSTS. A COMPLETE FINANCIAL DISBURSEMENT REPORT MUST BE RECEIVED WITHIN 30 DAYS AFTER THE CLOSE OF THE FIRST YEAR OF THE GRANT BEFORE CONSIDERATION WILL BE GIVEN FOR RENEWAL OF THE GRANT FOR THE SECOND YEAR. AT THE CONCLUSION OF THE GRANT, A COMPLETE FINANCIAL DISBURSEMENT REPORT COVERING THE ENTIRE GRANT PERIOD MUST BE COMPLETED BY THE PERSON RECEIVING THE GRANT FUNDS. ANY FUNDS USED FOR UNAUTHORIZED EXPENDITURES OR UNEXPENDED MUST BE RETURNED, WITH THE DISBURSEMENT REPORT, WITHIN 90 DAYS AFTER THE GRANT HAS TERMINATED. X X X 0 0 0 0 0 0 0 0 0 JIM BARANSKI EXECUTIVE DIRECTOR 206000 0 0 0 0 0 0 0 8770 0 214770 0 0 0 JULIE LEVINSON SISTER OF BOARD MEMBER DAVID LEVINSON WHO RETIRED FROM THE BOARD 3/31/2025 23400 FREELANCE COPYWRITER 0 X 1 26855 SELLING PRICE 0 0 0 PART I, COLUMN (B): THE NUMBER IN COLUMN (B) IS THE NUMBER OF CONTRIBUTIONS. FORM 990, PART VI, SECTION B, LINE 11B THE DRAFT FORM 990 IS REVIEWED BY THE LCFA CORPORATE OFFICERS, AND THEN SUBMITTED TO THE LCFA BOARD OF DIRECTORS FOR REVIEW AND COMMENT. FORM 990, PART VI, SECTION B, LINE 12C LCFA'S CONFLICT OF INTEREST POLICY IS REVIEWED ANNUALLY AND EACH DIRECTOR, OFFICER AND SENIOR STAFF MEMBER WILL CERTIFY ANNUALLY THAT HE OR SHE HAS RECEIVED, READ, UNDERSTOOD AND IS IN COMPLIANCE WITH, THE POLICY. IT IS THE RESPONSIBILITY OF EACH OFFICER AND DIRECTOR OF THE CORPORATION TO DISCHARGE HIS OR HER DUTIES AS A DIRECTOR AND OFFICER IN GOOD FAITH, IN A MANNER THE PERSON REASONABLY BELIEVES TO BE IN THE BEST INTERESTS OF THE CORPORATION, AND WITH THE CARE AN ORDINARILY PRUDENT PERSON IN A LIKE POSITION WOULD EXERCISE UNDER SIMILAR CIRCUMSTANCES. FORM 990, PART VI, SECTION B, LINE 15 LCFA IS REGULARLY AND CONSISTENTLY MONITORING THE PERFORMANCE AND SALARY OF THE EXECUTIVE DIRECTOR, OTHER OFFICERS, AND KEY EMPLOYEES. LCFA UTILIZED A COMPENSATION STUDY AND A COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 LCFA MAKES ALL GOVERNING DOCUMENTS AND FINANCIAL INFORMATION AVAILABLE TO THE PUBLIC ON REQUEST. FORM 990, PART IX, LINE 11G EDUCATION AWARENESS: PROGRAM SERVICE EXPENSES 476,121. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 476,121. PATIENT EDUCATION: PROGRAM SERVICE EXPENSES 224,125. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 224,125. SPEAKERS BUREAU: PROGRAM SERVICE EXPENSES 224,125. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 224,125. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 6,653. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 33,300. TOTAL EXPENSES 39,953. PROFESSIONAL COMPLIANCE FEES: PROGRAM SERVICE EXPENSES 7,784. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 666. TOTAL EXPENSES 8,450.